5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95
CAS1414773-56-0
5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95 (CAS 1414773-56-0) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
![Chemical structure of 5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95](https://chemsigma.com/chemicalStructure/14/1414773-56-0.png)
- CAS No.
- 1414773-56-0
Chemical Specifications
Identifiers
| CAS number | 1414773-56-0 |
|---|---|
| Product name | 5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95 |
| Chinese name | 5,6-二氢-1-苯基-8H-1,?2,?4-三唑[3,?4-?c]?[1,?4]噁唑鎓四氟硼酸盐 |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95?
The CAS Registry Number of 5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95 is 1414773-56-0.
How can I request a quotation for 5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95?
Send an inquiry for 5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95 (CAS 1414773-56-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 5,6-Dihydro-2-phenyl-8H-1,2,4-triazolo[3,4-c][1,4]oxazinium tetrafluoroborate, 95
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.